T2 Biosystems is a private biotechnology company developing next-generation medical diagnostic products using its proprietary technology to provide rapid, accurate and portable diagnostics. 

T2 Biosystems was founded in 2006 by renowned researchers from the Massachusetts Institute of Technology, Harvard University, Harvard Medical School and Massachusetts General Hospital, and has assembled a world-class team, board of directors and scientific advisory board that collectively have a proven track record of translating technologic innovations into breakthrough products, building significant corporate value.